NOV03

About Harrow Health

Harrow Health has established a distinctive and defensible position in the ophthalmic pharmaceutical sector through its vertically integrated business model, which pairs the recurring, high-margin revenue of its national compounding pharmacy, ImprimisRx, with a strategic portfolio of branded and generic products. Since its founding in 2011, the company has scaled to serve thousands of eyecare providers nationwide and, through seven strategic acquisitions, has assembled a portfolio of 17 branded products and 2 biosimilars. Its strategy centers on leveraging the deep customer relationships and distribution power of its compounding business to accelerate the commercialization of its expanding branded portfolio, targeting a broad range of ocular conditions from dry eye to retinal diseases.

Therapeutic Areas